Recellularization mechanisms in mononuclear cell seeded tissue engineered valves
单核细胞接种的组织工程瓣膜的再细胞化机制
基本信息
- 批准号:8969308
- 负责人:
- 金额:$ 7.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultBiochemicalBiologicalBiological AssayBioprosthesis deviceBiopsyBioreactorsBone MarrowCell Culture TechniquesCell FractionCell LineCell surfaceCellsChildClinicalClinical TreatmentCollagenComplexCongenital Heart DefectsConsensusCuesCustomCytokine SignalingDevelopmentDiseaseElastinExtracellular MatrixFaceGene ExpressionGene Expression ProfilingGrowthHeart ValvesHistological TechniquesHumanImmune responseImplantIn VitroInfiltrationInflammationInflammatoryInflammatory ResponseIntentionInvestigationLaboratoriesLeukocytesLifeLongevityMeasuresMechanicsMediatingMesenchymal Stem CellsModelingMononuclearOperative Surgical ProceduresPatientsPerformancePhasePhenotypePhysiologicalPopulationProcessProductionProliferatingProtocols documentationPulmonary valve structureRegenerative MedicineRepeat SurgeryRoleSafetyServicesSurfaceSystemTimeTissue EngineeringTissuesTranslationsaortic valvecalcificationclinical practiceconditioningcongenital heart disordercytokineheart valve replacementimplantationimprovedin vivointerestinterstitial cellmacrophagemonocyteparacrinepressureprotein expressionpublic health relevancerestorationscaffoldsemilunar valvesuccess
项目摘要
DESCRIPTION (provided by applicant): While tissue engineering offers the promise of improved clinical treatment for numerous disorders, obstacles that have limited the translation of laboratory successes into clinical practice must be overcome before this potential is realized. This holds true for the tissue engineered heart valve (TEHV), a living, growing valve substitute that would significantly improve the treatment of congenital heart disorders in children and degenerative valve disorders in adults. However, scientific and regulatory challenges limit the practicality and attractiveness of previous heart valve tissue engineering strategies. The use of complex bioreactors systems that are not disposable or patient-specific introduces a substantial regulatory obstacle that must be overcome. We have addressed this issue through the development of a fully disposable, single-use bioreactor for heart valve seeding and conditioning, permitting the investigation of clinically feasible TEHV processing strategies. Scaffold safety is also of major concern, as the implanted construct must be fully functional as a valve from the time of implantation forward. This concern can be mitigated through the use of decellularized heart valve scaffolds, which have a record of clinical safety; however, previous difficulties in introducing sub-surface cells into the leaflet of the decellularized heart valve hae dampened enthusiasm for this particular TEHV scaffold. Using our custom bioreactor, we have overcome this limitation, successfully creating a pilot population of bone marrow mononuclear cells (BM-MNCs) within the leaflet. The objectives of this project are to determine the potential for ex vivo maturation of this pilot BM-MNC population through extended bioreactor processing and to evaluate the subsequent in vitro inflammatory response to the seeded tissue. Two Specific Aims have been formulated to accomplish these objectives. In the first Aim, extended bioreactor processing will be utilized to determine the extent to which the pilot BM-MNC population proliferates and differentiates during the culture period. We will also evaluate the potential for remodeling of the decellularized scaffold. Aim 2 will utilize an in vitro macrophage cytokine signaling assay to assess the inflammatory response to the seeded tissue. Accomplishing these two Specific Aims will elucidate the recellularization mechanisms of the decellularized heart valve in the context of heart valve tissue engineering.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gabriel LeVerne Converse其他文献
Gabriel LeVerne Converse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
The search of the new natural organic compounds and analysis of their biochemical characters for development of the therapeutic drug against adult T-cell leukemia.
寻找新的天然有机化合物并分析其生化特性,用于开发成人T细胞白血病治疗药物。
- 批准号:
18K06732 - 财政年份:2018
- 资助金额:
$ 7.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 3: Adolescent vulnerability to chronic ethanol: neurophysiological, biochemical, and behavioral mechanisms of adult AUD
项目 3:青少年对慢性乙醇的脆弱性:成人 AUD 的神经生理学、生化和行为机制
- 批准号:
10310702 - 财政年份:2017
- 资助金额:
$ 7.5万 - 项目类别:
Microenvironmental control of adult stem cell differentiation: Influence of biochemical ECM composition, ECM stiffness and electric fields
成体干细胞分化的微环境控制:生化 ECM 成分、ECM 硬度和电场的影响
- 批准号:
277648419 - 财政年份:2015
- 资助金额:
$ 7.5万 - 项目类别:
Research Grants
Biochemical Markers in Adult Patients with Aneurysmal Subarachnoid Hemorrhage
成人动脉瘤性蛛网膜下腔出血患者的生化标志物
- 批准号:
7843707 - 财政年份:2009
- 资助金额:
$ 7.5万 - 项目类别:
BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE
动脉瘤性蛛网膜下腔出血成年患者的生化标志物
- 批准号:
7717128 - 财政年份:2007
- 资助金额:
$ 7.5万 - 项目类别:
ADVANCED NEUROMONITORING, AND BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURY
成年动脉瘤患者的高级神经监测和生化标记物
- 批准号:
7605460 - 财政年份:2006
- 资助金额:
$ 7.5万 - 项目类别:
ADVANCED NEUROMONITORING, AND BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURY
成年动脉瘤患者的高级神经监测和生化标记物
- 批准号:
7374658 - 财政年份:2005
- 资助金额:
$ 7.5万 - 项目类别:
ADVANCED NEUROMONITORING, AND BIOCHEMICAL MARKERS IN ADULT PATIENTS WITH ANEURY
成年动脉瘤患者的高级神经监测和生化标记物
- 批准号:
7202969 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
BIOCHEMICAL MECHANISMS IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的生化机制
- 批准号:
6272606 - 财政年份:1997
- 资助金额:
$ 7.5万 - 项目类别:
BIOCHEMICAL MECHANISMS IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的生化机制
- 批准号:
6241662 - 财政年份:1996
- 资助金额:
$ 7.5万 - 项目类别:














{{item.name}}会员




